Skip to main content
MedVellum
MCQsExamsAtlas
DashboardPricing
MBBS / Core medicine✳Dermatology✳ICU Fellowship (CICM)✳Anaesthesia✳Emergency Medicine✳Psychiatry Fellowship✳Paediatrics Fellowship✳Physician Medicine✳MCQs✳SAQs✳Vivas✳OSCE✳Evidence-first✳MBBS / Core medicine✳Dermatology✳ICU Fellowship (CICM)✳Anaesthesia✳Emergency Medicine✳Psychiatry Fellowship✳Paediatrics Fellowship✳Physician Medicine✳MCQs✳SAQs✳Vivas✳OSCE✳Evidence-first✳

MedVellum.

The folio

Exam-exhaustive medical education across every specialty — evidence-graded topics, engraved plates, and practice in every written and oral format. Educational content only — not medical advice.

llms.txt · psychiatry LLM catalog · sitemap

Atlas

  • Specialty atlas
  • MBBS / Core medicine
  • Dermatology
  • ICU Fellowship (CICM)
  • Anaesthesia
  • Emergency Medicine
  • Psychiatry Fellowship
  • Paediatrics Fellowship
  • Physician Medicine

Study & account

  • MCQ practice
  • Practice alias
  • Exam tools
  • Dashboard
  • Pricing
  • Sign in

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

Folio edition · Set in Instrument Serif & Archivo

Paeds Casesinfectious-diseases

Paeds Cases · infectious-diseases

The well-appearing child with a positive culture at 24 hours — structured encounter

A structured clinical encounter testing the modern approach to bacteraemia and occult bloodstream infection: assessment and risk-stratification of a well-appearing febrile child, a defensible discharge with a safety-net and named result ownership, and the response when a blood culture turns positive at 24 hours, including the distinction of pathogen from contaminant.

structured clinical encounter
On this page & tools

Target exams

RACP General PaediatricsRACP DCEMRCPCH ClinicalABP General PediatricsRCPSC Pediatrics

Target exams

RACP General PaediatricsRACP DCEMRCPCH ClinicalABP General PediatricsRCPSC Pediatrics
Prompt
A 14-month-old, fully immunised child was seen six hours ago with two days of fever to 39.5 °C, no focus, and a well appearance, and sent home with a safety-net. The laboratory now reports growth in both blood culture bottles at 24 hours.

Setting and candidate instructions

You are the paediatric registrar called by the microbiology laboratory at 14:00. Six hours ago, in the emergency department, you assessed a 14-month-old, fully immunised boy with two days of fever to 39.5 °C, no identifiable focus and a well appearance. You drew a blood culture, considered a urine test, and discharged him with a specific safety-net and a named clinician (you) as the owner of the pending result. The laboratory now reports growth in both blood culture bottles at 24 hours, with gram-positive cocci in pairs and chains on preliminary Gram stain. The examiner will ask you to manage the call, the recall and the reassessment, and to justify each decision. [1]

Information released on request

  1. At baseline (six hours ago): alert, smiling, drank well, clear chest, no rash, normal perfusion; observations age-appropriate; urine pending; blood culture drawn before discharge.
  2. On the call: growth in both bottles at 24 hours; preliminary Gram stain shows gram-positive cocci in pairs and chains; the child's family is contactable.
  3. On recall: the child is still febrile but alert, with reduced intake overnight and slightly reduced activity; no rash, no meningism, normal perfusion; observations are at the upper end of normal but he is not toxic. [10]

Examiner prompts

  1. "The laboratory calls you. What is your first action, and what is your reasoning?"
  2. "Gram-positive cocci in pairs and chains in both bottles. How do you interpret this — pathogen or contaminant, and why?"
  3. "The family is contactable and the child is recalled. Talk me through your reassessment."
  4. "He is febrile but not toxic. What is your disposition and your empiric therapy plan?"
  5. "Six hours ago you sent a well child home with a blood culture pending. Was that decision defensible in the modern era?"
  6. "What if the culture had grown coagulase-negative staphylococci in a single bottle instead?" [10]

Model performance

"My first action is to recall the child and reassess him, because growth in both bottles of a recognised pathogen is a true bacteraemia until proved otherwise. I named myself as the owner of this pending result at discharge, which is why I am the one receiving this call rather than discovering it later." [1] [10]

"Gram-positive cocci in pairs and chains growing in both bottles is most consistent with Streptococcus pneumoniae. Both bottles, a recognised pathogen and a compatible clinical context make this a pathogen, not a contaminant — in contrast to coagulase-negative staphylococci in a single bottle, which I would treat as a probable contaminant and manage by reassessment." [1]

"On reassessment he is still febrile but alert, with reduced intake and activity but no rash, no meningism and normal perfusion. He is not toxic. I examine for a focus, including ears, throat, chest, abdomen, skin and joints, and I look specifically for meningeal and neurological signs even though meningism is an imperfect sign at this age. I obtain repeat cultures and inflammatory markers, and I admit him for empirical intravenous therapy directed at pneumococcus and its potential complications, including meningitis." [1] [12]

"Six hours ago the decision to send a well-appearing vaccinated child home without empirical ceftriaxone was defensible, because conjugate vaccines have reduced the prevalence of occult bacteraemia in such children to well below one per cent, and the modern question is risk of invasive bacterial infection rather than chasing every culture. What made the discharge safe — and what makes this positive culture actionable rather than dangerous — is that I gave a specific safety-net and named myself as the owner of the pending result." [1] [3] [9]

"If the culture had grown coagulase-negative staphylococci in a single bottle, I would interpret it as a probable contaminant, read through the organism, the single-bottle growth and a well child, and manage it by clinical reassessment rather than reflex antibiotics. The presence of a central line, immunocompromise or a deteriorating child would change that interpretation, which is why organism, bottle count and host context are read together." [1] [10]

Marking domains

DomainWhat the candidate must demonstrate
Recall and reasoningRecognises both-bottle growth of a pathogen as bacteraemia; recalls and reassesses without delay.
Pathogen versus contaminantDistinguishes a recognised pathogen in both bottles from a single-bottle skin-flora contaminant, using organism, bottle count and host context.
Reassessment and therapyRe-examines for a focus including meningism; admits; empirical therapy; narrows once sensitivities return.
Justification of the original decisionExplains the conjugate-vaccine reframing and why discharge without empirical ceftriaxone was defensible.
Safety-net and result ownershipNames the specific safety-net and the named owner of the pending result that made the discharge safe.
Contingency reasoningCorrectly manages the alternative single-bottle contaminant scenario.
[1] [3] [9] [10] [12]

Disposition and safety-net standard for this encounter

The child is admitted for empirical intravenous therapy and observation. The family is given a specific bedside route to summon help for warning changes (reduced feeding, lethargy, rash, altered breathing, or failure to return to usual self). The team states the next sign of deterioration and the action while the organism and sensitivities are awaited. Every receiving team inherits responsibility for the pending sensitivities and the 24-hour follow-up. The named-owner principle that operated before discharge continues in reverse on admission: a positive result must reach a named clinician, and a decision to narrow, continue or stop therapy must be owned. "Return if worried" is not a substitute for any of this. [1] [12]

References

  1. [1]Gomez B Bacteremia in previously healthy children in emergency departments: clinical and microbiological characteristics and outcome European journal of clinical microbiology & infectious diseases, 2015.PMID 25252630
  2. [3]Pantell RH Evaluation and Management of Well-Appearing Febrile Infants 8 to 60 Days Old Pediatrics, 2021.PMID 34281996
  3. [9]Ben-Shimol S Dynamics of invasive pneumococcal disease in infants younger than 2 years old following PCV7/13 implementation using two infant and a booster dose schedule: evidence for indirect protection of young infants, Israel, 2004 to 2019 Euro surveillance, 2023.PMID 37347413
  4. [10]Gaur AH Optimizing blood culture practices in pediatric immunocompromised patients: evaluation of media types and blood culture volume The Pediatric infectious disease journal, 2003.PMID 12799512
  5. [12]Weiss SL Surviving Sepsis Campaign International Guidelines for the Management of Sepsis and Septic Shock in Children 2026 Pediatric critical care medicine, 2026.PMID 41869844